According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

Separately, the FDA expanded the indication for Vertex's Trikafta on Friday to include cystic fibrosis patients with additional genetic variants. The FDA initially approved Trikafta in 2019 for ...

TRIKAFTA, a combination of elexacaftor, tezacaftor, and ivacaftor, is designed to enhance the function of the defective protein caused by cystic fibrosis transmembrane conductance regulator (CFTR) ...

Vertex Pharmaceuticals (VRTX) announced the U.S. Food and Drug Administration has approved the expanded use of Trikafta for the treatment of people with cystic fibrosis ages 2 and older who have ...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA ® (elexacaftor ...

The tablet sold by Sotheby’s is the oldest known inscription in stone of the ancient text in Paleo-Hebrew script. Sharon Liberman Mintz, Sotheby's Judaica specialist, discusses the oldest ...

By Michael Levenson A stone tablet that was described by Sotheby’s as the oldest in the world inscribed with the Ten Commandments sold on Wednesday for just over $5 million to an anonymous buyer ...

Amazon just dropped the prices on two of their top tablets—now starting at $54.99. These deals are too good to last and perfect for all you last minute shoppers out there.